Réaction #92272

ord-330ca86bbc2e476fa190bb1e289da246

Équation de réaction

CCN(C(C)C)C(C)C
DIEA
CC1(c2cccc(F)c2)CCCN1c1ccn2ncc(N)c2n1
5-(2-(3-fluorophenyl)-2-methylpyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine
O=C(n1ccnc1)n1ccnc1
CDI
Cl.OC1CNC1
azetidin-3-ol hydrochloride
CC1(c2cccc(F)c2)CCCN1c1ccn2ncc(NC(=O)N3CC(O)C3)c2n1
final product
Rendement 55.0%
CC1(c2cccc(F)c2)CCCN1c1ccn2ncc(NC(=O)N3CC(O)C3)c2n1
N-(5-(2-(3-fluorophenyl)-2-methylpyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxyazetidine-1-carboxamide
Rendement 55.0%

Solvants

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    workup.STIRRINGThe reaction was stirred for 30 minutes before it
  2. 2
    Concentrationwas concentrated
  3. 3
    Autredirectly purified by reverse-phase column chromatography
  4. 4
    Lavageeluting with 0 to 60% acetonitrile/water

Mode opératoire

To a DCM (0.7 mL) solution of 5-(2-(3-fluorophenyl)-2-methylpyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine (25 mg, 0.08 mmol) was added CDI (20 mg, 0.12 mmol) at ambient temperature in one portion. After stirring one hour, azetidin-3-ol hydrochloride (20 mg, 0.12 mmol) was added in one portion, followed by addition of DIEA (0.028 mL, 0.16 mmol). The reaction was stirred for 30 minutes before it was concentrated and directly purified by reverse-phase column chromatography, eluting with 0 to 60% acetonitrile/water to yield the final product as a yellowish oil (18 mg, 55% yield). MS (apci) m/z=411.2 (M+H).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09447104B2uspto-grants-2016_09